66 related articles for article (PubMed ID: 20633643)
1. Comparing metoclopramide electrotransport kinetics in vitro and in vivo.
Cázares-Delgadillo J; Aziza IB; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Oct; 41(2):353-9. PubMed ID: 20633643
[TBL] [Abstract][Full Text] [Related]
2. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
3. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
[TBL] [Abstract][Full Text] [Related]
4. Controlled transdermal iontophoresis for poly-pharmacotherapy: Simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo.
Cázares-Delgadillo J; Ganem-Rondero A; Merino V; Kalia YN
Eur J Pharm Sci; 2016 Mar; 85():31-8. PubMed ID: 26826281
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
6. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565
[TBL] [Abstract][Full Text] [Related]
7. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
Dubey S; Kalia YN
J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
[TBL] [Abstract][Full Text] [Related]
8. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
Cázares-Delgadillo J; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Biopharm; 2010 Jun; 75(2):173-8. PubMed ID: 20332024
[TBL] [Abstract][Full Text] [Related]
9. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
Kalaria DR; Patel P; Patravale V; Kalia YN
Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444
[TBL] [Abstract][Full Text] [Related]
11. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin.
Abla N; Naik A; Guy RH; Kalia YN
J Control Release; 2005 Nov; 108(2-3):319-30. PubMed ID: 16169627
[TBL] [Abstract][Full Text] [Related]
12. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
13. Transdermal iontophoretic delivery of triptorelin in vitro.
Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
J Pharm Sci; 2005 Oct; 94(10):2175-82. PubMed ID: 16136544
[TBL] [Abstract][Full Text] [Related]
14. Effect of amino acid sequence on transdermal iontophoretic peptide delivery.
Schuetz YB; Naik A; Guy RH; Kalia YN
Eur J Pharm Sci; 2005 Dec; 26(5):429-37. PubMed ID: 16143501
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor.
Dubey S; Perozzo R; Scapozza L; Kalia YN
Mol Pharm; 2011 Aug; 8(4):1322-31. PubMed ID: 21696184
[TBL] [Abstract][Full Text] [Related]
16. Contributions of electromigration and electroosmosis to iontophoretic drug delivery.
Marro D; Kalia YN; Delgado-Charro MB; Guy RH
Pharm Res; 2001 Dec; 18(12):1701-8. PubMed ID: 11785689
[TBL] [Abstract][Full Text] [Related]
17. Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo.
Patel SR; Zhong H; Sharma A; Kalia YN
Eur J Pharm Biopharm; 2009 Jun; 72(2):304-9. PubMed ID: 18771728
[TBL] [Abstract][Full Text] [Related]
18. Extraction of amino acids by reverse iontophoresis: simulation of therapeutic monitoring in vitro.
Sieg A; Jeanneret F; Fathi M; Hochstrasser D; Rudaz S; Veuthey JL; Guy RH; Delgado-Charro MB
Eur J Pharm Biopharm; 2008 Nov; 70(3):908-13. PubMed ID: 18675906
[TBL] [Abstract][Full Text] [Related]
19. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
20. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1.
Dubey S; Kalia YN
J Control Release; 2011 Jun; 152(3):356-62. PubMed ID: 21397646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]